Publications / News

Carpenter RM, Young MK, Petri WAO, Lyons GR, Gilchrist C, Carey RM, Petri WA Jr.
Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.mSphere. 2022 Aug 31;7(4):e0022022. doi: 10.1128/msphere.00220-22. Epub 2022 Aug 1. PMID: 35913134  

Cottler PS, Kang H, Nash V, Salopek L, Bruce AC, Spiller KL, Campbell CA. Immunomodulation of Acellular Dermal Matrix Through Interleukin 4 Enhances Vascular Infiltration. Ann Plast Surg. 2022 Jun 1;88(5 Suppl 5): S466-S472. doi: 10.1097/SAP.0000000000003163. Epub 2022 Apr 23. PMID: 35502953  

Edmonds NL, Flores SE, Mahmutovic A, Young SJ, Mauldin IS, Slingluff CL Jr. .CD103 and periplakin are potential biomarkers for response of metastatic melanoma to pembrolizumab.Melanoma Res. 2022 Dec 1;32(6):440-450. doi: 10.1097/ CMR. 0000000000000855. Epub 2022 Sep 28. PMID: 3616998 

Edmonds NL, Gradecki SE, Katyal P, Lynch KT, Stowman AM, Gru AA, Engelhard VH, Slingluff CL Jr, Mauldin IS. Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas. Oncoimmunology. 2023 Jan 7;12(1):2164476. doi: 10.1080/2162402X.2022.2164476.  

 Griesinger L, Nyarko-Odoom A, Martinez SA, Shen NW, Ring KL, Gaughan EM, Mills AM .PD-L1 and MHC Class I Expression in High-grade Ovarian Cancers, Including Platinum-resistant Recurrences Treated With Checkpoint Inhibitor Therapy. Appl Immunohistochem Mol Morphol. 2023 Feb 22. doi: 10.1097/PAI.0000000 000001108. PMID: 36812389 

Lynch KT, Hu Y, Farrow NE, Song Y, Meneveau MO, Kwak M, Lowe MC, Bartlett EK, Beasley GM, Karakousis GC, Slingluff CL. Regional control after precision lymph node dissection for clinically evident melanoma metastasis. .J Surg Oncol. 2023 Jan;127(1):140-147. doi: 10.1002/jso.27100. Epub 2022 Sep 17. PMID: 36115028 

Lynch KT, Squeo GC, Kane WJ, Meneveau MO, Petroni G, Olson WC, Chianese-Bullock KA, Slingluff CL Jr, Foley EF, Friel CM. A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancer. Int J Cancer. 2022 Jan 1;150(1):164-173. doi: 10.1002/ijc.33793. Epub 2021 Oct 23. PMID: 34480368  

 Meneveau MO, Kumar P, Lynch KT, Patel SP, Slingluff CL The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling. J Immunother Cancer2022; 10(3): e003533. PMCID: PMC8919469. PMID: 35277457 

Mills AM, Bullock TN,Ring KL. . Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists. Modern Pathology (2022) 35:142–151; https://doi.org/10.1038/s41379-021-00882-y 

Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA Jr. Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial. medRxiv. 2022 May 19:2022.03.30.22273194. doi : 10.1101/2022.03.30.22273194. PMID: 35411349  

Sasson J, Moreau GB, Petri WA Jr. The Role of IL-13 and the Type 2 Immune Pathway in COVID-19: A Review. Ann Allergy Asthma Immunol. 2023 Mar 14: S1081-1206(23)00172-2. doi: 10.1016/j.anai.2023.03.009. PMID: 36924937  

Tran CA, L:ynch KT, Meneveau, MO, Katya,P,Olson WC,Slingluff,CL.  Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine. J Immunother Cancer. 2023, Feb:11(2).doi:.10.1136/jitc-2022-005952. PMID: 36746511. 

Vavolizza RD, Petroni GR, Mauldin IS, Chianese-Bullock KA, Olson WC, Smith KT, Dengel LT, Haden K, Grosh WW, Kaur V, Varhegyi N, Gaughan EM, Slingluff CL Jr. Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). J Immunother Cancer. 2022 Sep;10(9):e005424. doi: 10.1136/jitc-2022-005424.